Therapeutics Initiative Profile picture
UBC-based, independent, evidence-informed, practical #BetterPrescribing information for #Physicians, #NursePractitioners, #Pharmacists #MedEd #CME RT≠endorse

Jun 30, 2021, 6 tweets

THREAD:5⃣things to know from 5 recent TI Therapeutics Letters👩🏽‍🔬

1/5: How to choose a good #mirtazapine dose? 🤔

Mirtazapine has a dose response 💊for harm but NOT for efficacy: harm ↗️ after 30mg/day but efficacy doesn't: bit.ly/361LU9E

#MedEd #deprescribing #ptsafety

2/5: Want to learn about recent @GovCanHealth #medsafety or international warnings for medications?

Read our Therapeutics Letter on international drug safety advisories: bit.ly/3wc0ar8 ⚠️ 💊

#drugsafety #SegPac #ptsafety

3/5: Do you like receiving feedback on your #prescribing?👩🏽‍⚕️💊

Read about Personal Prescribing Portraits: bit.ly/3hkf8WO

#MedEd #deprescribing

4/5: Can pill splitting 💊 save your patients some money?💰

Example:
Atorvastatin 80mg tablets. Dispense 45 to last 90d. Take ½ = 40mg/day for secondary prevention of ischemic heart disease complications

Full Letter: bit.ly/3dxlKzM

#MedEd #prescribing

5/5: Do hospital pts need VTE prophylaxis?🤔

Less than 2% will get #DVT & prophylaxis hasn’t been shown to ↘️ mortality. No conclusive evidence that symptomatic DVT is reduced with prophylaxis😯

Full Letter: bit.ly/3yeaNv9

#MedEd #ptsafety #SegPac #PulmonaryEmbolism

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling